Harbin Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Harbin China (1926)

Organization Overview

First Clinical Trial
2004
NCT00630747
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cancer Hospital Affiliated to Harbin Medical University | Cancer Hospital of Harbin Medical University | Cardiovascular Department, the First Affiliated Hospital of Harbin Medical University | Center of First Affiliated Hospital of Harbin Medical University | Department of Abdominal Surgery, Harbin Medical University Cancer Hospital | First Affiliated Hospital of Harbin Medical University | Harbin Chest Hospital | Harbin Clinic | Harbin Hematology and Oncology Institute | Harbin Institute of Hematology & Oncology | Harbin Medical University | Harbin Medical University Cancer Hospital,Gastrointestinal Surgical department | Harbin Medical University Cancer Hosptital | Harbin Medical University Third Affiliated Hospital | Institute of Hematology and Oncology, Harbin The First Hospital | Study Principal Investigator Harbin Medical University Cancer Hosptital | The Affiliated Cancer Hospital of Harbin Medical University | The Affiliated Tumor Hospital of Harbin Medical University | The first clinical college of harbin medical university | The Fourth Affiliated Hospital of Harbin Medical University | The Fourth Hospital of Harbin Medical University | The Second Affiliated Hospital of Harbin Medical University | The Third Affiliated hospital of Harbin Medical University | The Third Affiliated Hospital of Harbin Medical University | The Tumor Hospital Affiliated to Harbin Medical University | The tumor hospital of Harbin medical university | Xiaoyi Huang | Yu Bo